---
layout: post
title: "Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction"
date: 2026-02-05 18:57:49 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-00852
original_published: 2022-01-24 00:00:00 +0000
significance: 8.00
---

# Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 24, 2022 00:00 UTC
**Document Number:** 2022-00852

## Summary

The Drug Enforcement Administration (DEA) published a document in the Federal Register on August 12, 2021, concerning a notice of application. The document indicated the approved drug code (1205-- Lisdexamfetamine) as a schedule I. The correct drug schedule should read schedule II.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/24/2022-00852/importer-of-controlled-substances-application-globyz-pharma-llc-correction)
- API: https://www.federalregister.gov/api/v1/documents/2022-00852

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
